HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in HCW Biologics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −7 vs. Q1 2025
- Shares held
- 21.6K
- −1.13M (−98.1%) vs. Q1 2025
- Total value
- $85.5K
- −$240.5K (−73.8%) vs. Q1 2025
- New holders
- 5
- 1 more added
- Sold out
- 12
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HCWB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $515.7K |
| Q1 2026 | 15 | $160.8K |
| Q4 2025 | 14 | $424.1K |
| Q3 2025 | 10 | $456.9K |
| Q2 2025 | 8 | $85.5K |
| Q1 2025 | 15 | $326.0K |
| Q4 2024 | 18 | $1.40M |
| Q3 2024 | 16 | $625.6K |
| Q2 2024 | 19 | $784.3K |
| Q1 2024 | 20 | $1.90M |
| Q4 2023 | 19 | $1.30M |
| Q3 2023 | 14 | $1.93M |
| Q2 2023 | 13 | $2.17M |
| Q1 2023 | 13 | $1.22M |
| Q4 2022 | 14 | $1.50M |
| Q3 2022 | 13 | $1.50M |
| Q2 2022 | 13 | $1.25M |
| Q1 2022 | 13 | $1.48M |
| Q4 2021 | 13 | $855.0K |
| Q3 2021 | 9 | $512.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding HCW Biologics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Golden State Wealth Management, LLC | 10,000 | $39.6K | 0.00% | +10,000 | New |
| UBS Group AG | 9,518 | $37.7K | 0.00% | +9,518 | New |
| Wells Fargo & Company | 1,700 | $6.74K | 0.00% | +1,700 | New |
| Tower Research Capital LLC (TRC) | 250 | $991 | 0.00% | +218+681.3% | Added |
| Fortitude Family Office, LLC | 58 | $230 | 0.00% | +58 | New |
| Advisor Group Holdings, Inc. | 26 | $103 | 0.00% | −984−97.4% | Reduced |
| Bank of America Corp | 10 | $40 | 0.00% | −200−95.2% | Reduced |
| SBI Securities Co., Ltd. | 6 | $24 | 0.00% | +6 | New |
| Avantax Planning Partners, Inc. | 0 | $0 | 0.00% | −279,541−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −243,158−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −236,967−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −131,990−100.0% | Sold out |
| Pullen Investment Management, LLC | 0 | $0 | 0.00% | −75,116−100.0% | Sold out |
| J.W. Cole Advisors, Inc. | 0 | $0 | 0.00% | −53,402−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −42,182−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −21,446−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −16,264−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −14,047−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −10,205−100.0% | Sold out |